Results for
""Isradipine""[mesh_terms]

A review of calcium channel antagonists in the treatment of pediatric hypertension.

Shobha Sahney

Paediatric drugs 2007;8(6):357-73

Applications of isradipine in human addiction studies: A systematic literature review.

Cara C Young, Samantha Natal, Karamveer Kaur, Eli S Gebhardt, Alexander Perrone, Hitoshi Morikawa, Carlos Tirado, Jasper A J Smits

Experimental and clinical psychopharmacology 2023;31(2):507-522

Tolerability of isradipine in early Parkinson's disease: a pilot dose escalation study.

Tanya Simuni, Emily Borushko, Michael J Avram, Scott Miskevics, Audrey Martel, C Zadikoff, Aleksandar Videnovic, Frances M Weaver, Karen Williams, D James Surmeier

Movement disorders : official journal of the Movement Disorder Society 2011;25(16):2863-6

A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.

A Cipriani, K Saunders, M-J Attenburrow, J Stefaniak, P Panchal, S Stockton, T A Lane, E M Tunbridge, J R Geddes, P J Harrison

Molecular psychiatry 2017;21(10):1324-32

Effects of antihypertensive therapy on hemorheological profiles in female hypertensive patients with initially low or high whole blood viscosity.

Adrei V Zamishlayev, Vladimir V Yakusevich, Herbert J Meiselman, Alexei V Muravyov

Clinical hemorheology and microcirculation 2003;26(2):125-35

Isradipine treatment of hypertension in children: a single-center experience.

Stephen J Warnick, Joseph T Flynn

Pediatric nephrology (Berlin, Germany) 2003;17(9):748-53

Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study.

J W de Fijter, W Weimar, A M Tegzess, A J Hoitsma, J A Bruijn, J P van Hooff, P G Mulder, I C van Riemsdijk

Transplantation 2000;70(1):122-6

Glycemia in newborns of hypertensive mothers according to maternal treatment.

Silvana Darcie, Cléa R Leone, Valdenise M L T Calil, Elizete P Prescinotti, Soubhi Kahhale, Marcelo Zugaib

Revista do Hospital das Clinicas 2006;59(5):244-50

Inactivation induced by pathogenic Ca1.3 L-type Ca-channel variants enhances sensitivity for dihydropyridine Ca channel blockers.

Jan Matthes, Jörg Striessnig, Monica L Fernández-Quintero, Nadine J Ortner, Ferenc Török, Sarah Salamon

British journal of pharmacology 2024;182(1):181-197

Treatment advances for cocaine-induced ischemic stroke: focus on dihydropyridine-class calcium channel antagonists.

B A Johnson, M D Devous, P Ruiz, N Ait-Daoud

The American journal of psychiatry 2001;158(8):1191-8

Re-Analysis of the STEADY-PD II Trial-Evidence for Slowing the Progression of Parkinson's Disease.

D James Surmeier, Jack T Nguyen, Nicola Lancki, Charles S Venuto, David Oakes, Tanya Simuni, Richard K Wyse

Movement disorders : official journal of the Movement Disorder Society 2022;37(2):334-342

Bioavailability and pharmacokinetics of isradipine after oral and intravenous administration: half-life shorter than expected?

K Antonsen, J P Kampmann, H R Angelo, J Bonde, A Lindekaer, K Simonsen, H R Christensen

Pharmacology & toxicology 2000;86(4):178-82

Isradipine Versus Placebo in Early Parkinson Disease.

Annals of internal medicine 2020;172(9):

A Clinical Trial of Isradipine: What Went Wrong?

Baijayanta Maiti, Joel S Perlmutter

Annals of internal medicine 2020;172(9):625-626

Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.

Jirí Widimský, Jana Sirotiaková

Current medical research and opinion 2006;22(7):1287-94